CA2272138C - Composes de pyrazolopyrimidine et de pyrazolopyridine ayant une activite antagoniste crf - Google Patents

Composes de pyrazolopyrimidine et de pyrazolopyridine ayant une activite antagoniste crf Download PDF

Info

Publication number
CA2272138C
CA2272138C CA002272138A CA2272138A CA2272138C CA 2272138 C CA2272138 C CA 2272138C CA 002272138 A CA002272138 A CA 002272138A CA 2272138 A CA2272138 A CA 2272138A CA 2272138 C CA2272138 C CA 2272138C
Authority
CA
Canada
Prior art keywords
alkyl
compound
formula
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002272138A
Other languages
English (en)
Other versions
CA2272138A1 (fr
Inventor
Willard M. Welch, Jr.
William S. Faraci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority claimed from CA002150483A external-priority patent/CA2150483C/fr
Publication of CA2272138A1 publication Critical patent/CA2272138A1/fr
Application granted granted Critical
Publication of CA2272138C publication Critical patent/CA2272138C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002272138A 1992-12-17 1993-11-03 Composes de pyrazolopyrimidine et de pyrazolopyridine ayant une activite antagoniste crf Expired - Fee Related CA2272138C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99222592A 1992-12-17 1992-12-17
US07/992,225 1992-12-17
CA002150483A CA2150483C (fr) 1992-12-17 1993-11-03 Pyrazoles et pyrazolopyrimidines pouvant servir d'antagonistes du crf

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002150483A Division CA2150483C (fr) 1992-12-17 1993-11-03 Pyrazoles et pyrazolopyrimidines pouvant servir d'antagonistes du crf

Publications (2)

Publication Number Publication Date
CA2272138A1 CA2272138A1 (fr) 1994-06-23
CA2272138C true CA2272138C (fr) 2002-03-05

Family

ID=25677980

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002272136A Expired - Fee Related CA2272136C (fr) 1992-12-17 1993-11-03 Derives de pyrasole ayant une activite antagoniste crf
CA002272138A Expired - Fee Related CA2272138C (fr) 1992-12-17 1993-11-03 Composes de pyrazolopyrimidine et de pyrazolopyridine ayant une activite antagoniste crf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002272136A Expired - Fee Related CA2272136C (fr) 1992-12-17 1993-11-03 Derives de pyrasole ayant une activite antagoniste crf

Country Status (1)

Country Link
CA (2) CA2272136C (fr)

Also Published As

Publication number Publication date
CA2272136C (fr) 2004-12-07
CA2272138A1 (fr) 1994-06-23
CA2272136A1 (fr) 1994-06-23

Similar Documents

Publication Publication Date Title
AU690527B2 (en) Pyrazoles having CRF antagonist activity
US6005109A (en) Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
EP1932833B1 (fr) Compose heterocyclique azote et composition pharmaceutique le contenant
CA2150709C (fr) Pyrazolopyrimidines
JP4426660B2 (ja) ピラゾール誘導体、その製法および医薬としてのその使用
WO1994013676A1 (fr) Pyrrolopyrimidines en tant qu'antagonistes du facteur liberateur de corticotrophine (crf)
JPH0623193B2 (ja) 新規なジスタマイシンａ同族体、その製造方法およびそれを含有する医薬組成物
NZ578568A (en) 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl] benzoic acid as 11-beta-HSD1 inhibitors
IE83508B1 (en) Quinoxalines, processes for their preparation, and their use
CZ293825B6 (cs) ChinoxalinyŹ způsob jejich výroby a jejich použití a farmaceutické prostředky tyto látky obsahující
US5847136A (en) Deazapurine derivatives; a new class of CRF1 specific ligands
JPS5930713B2 (ja) 新規な置換６−アリ−ル−４Ｈ−Ｓ−トリアゾロ−〔３，４Ｃ〕−チエノ−〔２，３ｅ〕−１，４−ジアゼピン類の製造方法
JP2707936B2 (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
JPH11240832A (ja) アミド若しくはアミン誘導体
JPS60214778A (ja) Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
US6103900A (en) Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
JPS62215582A (ja) オメガ−〔（ヘテロ）アルキル〕ベンズ〔ｃｄ〕インド−ル−２−アミン類及びその製造法
CA2272138C (fr) Composes de pyrazolopyrimidine et de pyrazolopyridine ayant une activite antagoniste crf
JPS59181265A (ja) ピリミジン誘導体
JPH02501064A (ja) 強心作用を有するイミダゾリルフエニルピロール‐２‐オン
McFadden et al. Synthesis of Pyrazoles and Pyrazolo [1, 5-a] pyrimidines from 3-Arylsulfonylaminoacrylates
CN118165004A (zh) 一种Type-II型GSK-3β抑制剂及其制备方法与应用
JPS635089A (ja) １，４−ジヒドロピリジン誘導体、その製造方法及びその化合物を含有する医薬
AU690090C (en) Pyrrolopyrimidines as CRF antagonists
HU211646A9 (hu) Pirazol-pirimidinon antianginás szerek Az átmeneti oltalom az 1-5. igénypontokra vonatkozik.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed